ASD and ADHD Comorbidity: What Are We Talking About?
agitation
attention
attention deficit and hyperactivity disorder
autism
autism spectrum disorder
comorbidity
restlessness
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
12
2021
accepted:
24
01
2022
entrez:
17
3
2022
pubmed:
18
3
2022
medline:
18
3
2022
Statut:
epublish
Résumé
According to the scientific literature, 50 to 70% of individuals with autism spectrum disorder (ASD) also present with comorbid attention deficit hyperactivity disorder (ADHD). From a clinical perspective, this high rate of comorbidity is intriguing. What is the real significance of this dual diagnosis? Is ADHD in fact always present in such cases? Might the attentional impairment reported among our ASD patients actually be a distinct trait of their ASD-namely, impaired joint attention-rather than an ADHD attention deficit? Could their agitation be the consequence of this joint attention impairment or related to a physical restlessness etiologically very different from the agitation typical of ADHD? The neurobiological reality of ASD-ADHD comorbidity is a subject of debate, and amphetamine-based treatment can have paradoxical or undesirable effects in the ASD population. Consequently, does a dual diagnosis, notwithstanding its currency in the literature, prevent us from shedding sufficient light on major physiopathologic questions raised by the clinical picture of ASD?
Identifiants
pubmed: 35295773
doi: 10.3389/fpsyt.2022.837424
pmc: PMC8918663
doi:
Types de publication
Journal Article
Langues
eng
Pagination
837424Informations de copyright
Copyright © 2022 Hours, Recasens and Baleyte.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Brain Res Cogn Brain Res. 1999 May;8(1):61-71
pubmed: 10216274
PLoS One. 2018 Nov 14;13(11):e0207286
pubmed: 30427902
Neurosci Biobehav Rev. 2011 Apr;35(5):1081-8
pubmed: 21093480
Expert Rev Mol Med. 2011 Mar 23;13:e9
pubmed: 21426626
J Am Acad Child Adolesc Psychiatry. 2012 Nov;51(11):1160-1172.e3
pubmed: 23101742
Int J Psychophysiol. 2009 Feb;71(2):124-31
pubmed: 19022305
Trends Cogn Sci. 2005 Dec;9(12):585-94
pubmed: 16289871
Neurosci Biobehav Rev. 2019 Jan;96:93-115
pubmed: 30367918
Trends Cogn Sci. 2017 Apr;21(4):290-302
pubmed: 28238605
Mol Psychiatry. 2018 Feb;23(2):257-262
pubmed: 28242872
Psychiatry Res. 2014 Aug 30;223(2):113-20
pubmed: 24929553
PLoS One. 2017 May 3;12(5):e0175870
pubmed: 28467487
Philos Trans R Soc Lond B Biol Sci. 2003 Feb 28;358(1430):315-24
pubmed: 12639329
Res Dev Disabil. 2021 Apr;111:103882
pubmed: 33548744
Eur Child Adolesc Psychiatry. 2018 Jul;27(7):899-908
pubmed: 29224173
J Autism Dev Disord. 2009 Mar;39(3):495-510
pubmed: 18850262
Neurosci Bull. 2017 Apr;33(2):219-237
pubmed: 28283808
Clin Neurophysiol. 2013 Apr;124(4):644-57
pubmed: 23063669
Res Dev Disabil. 2020 Aug;103:103682
pubmed: 32442872
J Commun Disord. 2017 Sep;69:27-43
pubmed: 28704690
J Child Psychol Psychiatry. 2004 Sep;45(6):1115-22
pubmed: 15257668
Res Dev Disabil. 2013 Oct;34(10):3545-52
pubmed: 23973801
Autism. 2010 Sep;14(5):408-29
pubmed: 20926457
Autism. 2006 Mar;10(2):155-72
pubmed: 16613865
Res Dev Disabil. 2015 Dec;47:175-84
pubmed: 26433184
Clin Neurophysiol. 2003 Feb;114(2):171-83
pubmed: 12559224
Neuroimage Clin. 2017 Jan 09;14:112-121
pubmed: 28180069
Front Hum Neurosci. 2013 Aug 05;7:442
pubmed: 23935579